Lack Of Misstatement Leads To Dismissal Of Stock-Drop Claims Against Drug Company

BOSTON — Dismissal of claims in a shareholder class action lawsuit against a biopharmaceutical company and two of its senior executives is necessary because a shareholder failed to plead any material...

Already a subscriber? Click here to view full article